ATE180057T1 - Elektrochemilumineszente testverfahren - Google Patents
Elektrochemilumineszente testverfahrenInfo
- Publication number
- ATE180057T1 ATE180057T1 AT89913023T AT89913023T ATE180057T1 AT E180057 T1 ATE180057 T1 AT E180057T1 AT 89913023 T AT89913023 T AT 89913023T AT 89913023 T AT89913023 T AT 89913023T AT E180057 T1 ATE180057 T1 AT E180057T1
- Authority
- AT
- Austria
- Prior art keywords
- analyte
- interest
- sample
- test methods
- luminesce
- Prior art date
Links
- 238000010998 test method Methods 0.000 title 1
- 239000012491 analyte Substances 0.000 abstract 6
- 239000000126 substance Substances 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000004020 luminiscence type Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/66—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light electrically excited, e.g. electroluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/66—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light electrically excited, e.g. electroluminescence
- G01N21/69—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light electrically excited, e.g. electroluminescence specially adapted for fluids, e.g. molten metal
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
- G01N2458/30—Electrochemically active labels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Control Of El Displays (AREA)
- Control Of Indicators Other Than Cathode Ray Tubes (AREA)
- Structures Of Non-Positive Displacement Pumps (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26688288A | 1988-11-03 | 1988-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE180057T1 true ATE180057T1 (de) | 1999-05-15 |
Family
ID=23016372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89913023T ATE180057T1 (de) | 1988-11-03 | 1989-10-31 | Elektrochemilumineszente testverfahren |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP0757252A3 (de) |
| JP (1) | JP2992974B2 (de) |
| KR (1) | KR0143993B1 (de) |
| AT (1) | ATE180057T1 (de) |
| AU (1) | AU637775B2 (de) |
| CA (1) | CA2002101C (de) |
| DE (1) | DE68928994T2 (de) |
| IL (1) | IL92164A (de) |
| SG (1) | SG60022A1 (de) |
| WO (1) | WO1990005301A1 (de) |
| ZA (1) | ZA898290B (de) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5705402A (en) * | 1988-11-03 | 1998-01-06 | Igen International, Inc. | Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets |
| US6274325B1 (en) | 1990-06-25 | 2001-08-14 | Boehringer Mannheim Gmbh | Method for carrying out a homogeneous-immunoassay based on agglutination |
| IL100867A (en) * | 1991-02-06 | 1995-12-08 | Igen Inc | Method and apparatus for improved luminescence assays |
| JPH0534345A (ja) * | 1991-02-19 | 1993-02-09 | Tdk Corp | 化学発光を利用する抗原・抗体の測定方法 |
| ATE184320T1 (de) * | 1991-07-10 | 1999-09-15 | Igen Int Inc | Verfahren für verbesserte lumineszenz-assays unter verwendung von teilchenkonzentration und chemilumineszenznachweis |
| DE69228817T2 (de) * | 1991-07-26 | 1999-09-23 | Dade Chemistry Systems Inc., Deerfield | Signalerkennungspruefung in der anwesenheit von einem suspendierten festen träger |
| ZA929351B (en) * | 1991-12-11 | 1993-06-04 | Igen Inc | Electrochemiluminescent label for DNA assays. |
| US5541113A (en) * | 1993-09-22 | 1996-07-30 | Beckman Instruments, Inc. | Method for detecting an analyte using an electrochemical luminescent transition metal label |
| CN1114106C (zh) * | 1994-07-25 | 2003-07-09 | 罗切诊断学有限公司 | 金属螯合物标记的肽及其制备方法 |
| US5660991A (en) * | 1994-10-28 | 1997-08-26 | Lakowicz; Joseph R. | Long lifetime anisotropy (polarization) probes for clinical chemistry, immunoassays, affinity assays and biomedical research |
| US5744367A (en) * | 1994-11-10 | 1998-04-28 | Igen International, Inc. | Magnetic particle based electrochemiluminescent detection apparatus and method |
| AU4756296A (en) * | 1995-01-06 | 1996-07-24 | Igen, Inc. | Electrogenerated chemiluminescence through enhanced particle luminescence |
| JPH11502617A (ja) * | 1995-03-10 | 1999-03-02 | メソ スケール テクノロジーズ，エルエルシー | 多重アレイの多重特異的な電気化学発光試験 |
| US6140045A (en) * | 1995-03-10 | 2000-10-31 | Meso Scale Technologies | Multi-array, multi-specific electrochemiluminescence testing |
| US6207369B1 (en) | 1995-03-10 | 2001-03-27 | Meso Scale Technologies, Llc | Multi-array, multi-specific electrochemiluminescence testing |
| US6673533B1 (en) | 1995-03-10 | 2004-01-06 | Meso Scale Technologies, Llc. | Multi-array multi-specific electrochemiluminescence testing |
| US6319670B1 (en) * | 1995-05-09 | 2001-11-20 | Meso Scale Technology Llp | Methods and apparatus for improved luminescence assays using microparticles |
| WO1996036870A1 (en) * | 1995-05-18 | 1996-11-21 | Igen, Inc. | Method for derivitizing electrodes and assay methods using such derivitized electrodes |
| US7070921B2 (en) | 2000-04-28 | 2006-07-04 | Molecular Devices Corporation | Molecular modification assays |
| US7632651B2 (en) | 1997-09-15 | 2009-12-15 | Mds Analytical Technologies (Us) Inc. | Molecular modification assays |
| EP0957360B1 (de) | 1998-05-06 | 2002-07-31 | Roche Diagnostics GmbH | Entstörung durch Rheumafaktoren |
| US6420109B1 (en) | 1998-09-11 | 2002-07-16 | Genelabs Technologies, Inc. | Nucleic acid ligand interaction assays |
| US6136268A (en) * | 1999-08-17 | 2000-10-24 | Orion Diagnostica | Method for luminescence measurements |
| AU2002341621A1 (en) * | 2001-09-10 | 2003-03-24 | Meso Scale Technologies, Llc | Methods, reagents, kits and apparatus for protein function analysis |
| US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
| US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
| US20070045902A1 (en) | 2004-07-13 | 2007-03-01 | Brauker James H | Analyte sensor |
| US8989833B2 (en) | 2004-07-13 | 2015-03-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
| JP4902674B2 (ja) | 2006-03-09 | 2012-03-21 | エフ．ホフマン−ラ ロシュ アーゲー | 抗薬物抗体アッセイ法 |
| JP4964957B2 (ja) | 2006-09-12 | 2012-07-04 | エフ．ホフマン−ラ ロシュ アーゲー | 抗薬物抗体アッセイ |
| ATE530907T1 (de) | 2007-02-27 | 2011-11-15 | Hoffmann La Roche | Verfahren zur beurteilung der hemmungsaktivität von antikörpern gegen insulinartigen wachstumsfaktor-1-rezeptor |
| CA2709127C (en) | 2007-12-15 | 2013-11-12 | F. Hoffmann-La Roche Ag | Distinguishing assay |
| US8264347B2 (en) | 2008-06-24 | 2012-09-11 | Trelleborg Sealing Solutions Us, Inc. | Seal system in situ lifetime measurement |
| US8614297B2 (en) | 2008-12-22 | 2013-12-24 | Hoffmann-La Roche Inc. | Anti-idiotype antibody against an antibody against the amyloid β peptide |
| JP5805190B2 (ja) | 2010-08-19 | 2015-11-04 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 療法用モノクローナル抗体に結合する抗体の測定のためのアッセイ |
| WO2012143380A1 (en) | 2011-04-20 | 2012-10-26 | F. Hoffmann-La Roche Ag | Microwaves for immunohistochemical analysis |
| CN103649125A (zh) | 2011-06-22 | 2014-03-19 | 霍夫曼-拉罗奇有限公司 | 利用包含mhc i类的复合物通过循环中的病毒特异性细胞毒性t细胞清除靶细胞 |
| CA2853917A1 (en) | 2011-12-19 | 2013-06-27 | F. Hoffmann-La Roche Ag | Method for the detection of free binding partner of a multispecific binder |
| WO2013113663A1 (en) | 2012-02-01 | 2013-08-08 | F. Hoffmann-La Roche Ag | Method for the detection of a binding partner of a multispecific binder |
| KR102084805B1 (ko) | 2012-03-08 | 2020-03-04 | 에프. 호프만-라 로슈 아게 | 순환 면역 복합체의 특성화를 위한 다중 크로마토그래피-면역분석 방법 |
| ES2627482T3 (es) | 2012-07-13 | 2017-07-28 | F. Hoffmann-La Roche Ag | Procedimiento para la detección de una proteína de unión multiespecífica |
| WO2014096015A1 (en) | 2012-12-21 | 2014-06-26 | F. Hoffmann-La Roche Ag | Disulfide-linked multivalent mhc class i comprising multi-function proteins |
| BR112015032960B1 (pt) | 2013-07-04 | 2021-01-05 | F. Hoffmann-La Roche Ag | imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro |
| KR102425339B1 (ko) | 2014-12-08 | 2022-07-25 | 에프. 호프만-라 로슈 아게 | 비타민 d 의 측정을 위한 방법 |
| JP6979941B2 (ja) | 2015-08-20 | 2021-12-15 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Ｐｅｇ化分析物特異的結合剤を用いた粒子に基づくイムノアッセイ |
| WO2017072210A1 (en) | 2015-10-29 | 2017-05-04 | F. Hoffmann-La Roche Ag | Anti-variant fc-region antibodies and methods of use |
| CA3004199C (en) | 2015-11-30 | 2024-05-07 | F. Hoffmann-La Roche Ag | Immunoassay for the determination of fc-region modified antibodies |
| BR112018017336A2 (pt) | 2016-03-07 | 2018-12-26 | Hoffmann La Roche | método in vitro para detectar um anticorpo para p53 (anticorpo anti-p53) em uma amostra e polipeptídeo de fusão |
| JP7068323B2 (ja) | 2017-02-02 | 2022-05-16 | エフ．ホフマン－ラ ロシュ アーゲー | 少なくとも２種のペグ化された分析物特異的結合剤を使用する免疫アッセイ |
| MX2020004921A (es) | 2017-11-29 | 2020-08-27 | Hoffmann La Roche | Ensayo de anticuerpo antifarmaco con supresion de interferencia del objetivo. |
| EP3781600A1 (de) | 2018-04-18 | 2021-02-24 | F. Hoffmann-La Roche AG | Neuartige anti-thymidinkinase-antikörper |
| JP7577647B2 (ja) | 2018-08-31 | 2024-11-05 | エフ． ホフマン－ラ ロシュ アーゲー | Ｄｌｂｃｌについての予後指標におけるチミジンキナーゼ（ｔｋ－１） |
| EP3902830A1 (de) | 2018-12-30 | 2021-11-03 | F. Hoffmann-La Roche AG | Antikörper gegen karnickel-cd19 und verfahren zur verwendung |
| WO2020229378A1 (en) | 2019-05-13 | 2020-11-19 | F. Hoffmann-La Roche Ag | Interference-suppressed pharmacokinetic immunoassay |
| EP4004551A1 (de) | 2019-07-22 | 2022-06-01 | F. Hoffmann-La Roche AG | Substanz p als blutbiomarker zur nichtinvasiven diagnose von endometriose |
| WO2021013783A1 (en) | 2019-07-22 | 2021-01-28 | F. Hoffmann-La Roche Ag | S100a12 as blood biomarker for the non-invasive diagnosis of endometriosis |
| EP4004553A1 (de) | 2019-07-22 | 2022-06-01 | F. Hoffmann-La Roche AG | S100a8 als blutbiomarker zur nichtinvasiven diagnose von endometriose |
| WO2021013785A1 (en) | 2019-07-22 | 2021-01-28 | F. Hoffmann-La Roche Ag | S100a9 as blood biomarker for the non-invasive diagnosis of endometriosis |
| EP4004555A1 (de) | 2019-07-22 | 2022-06-01 | F. Hoffmann-La Roche AG | S100a6 als blutbiomarker zur nichtinvasiven diagnose von endometriose |
| KR20220100883A (ko) | 2019-11-15 | 2022-07-18 | 에프. 호프만-라 로슈 아게 | 환자 샘플의 질량분석법 측정을 위한 베타-락탐 항생제의 유도체화 |
| EP4085251B1 (de) | 2020-01-02 | 2024-07-31 | F. Hoffmann-La Roche AG | Verfahren zur bestimmung der menge eines therapeutischen antikörpers im gehirn |
| KR102836238B1 (ko) | 2020-06-16 | 2025-07-18 | 에프. 호프만-라 로슈 아게 | 샘플에서 항체의 유리 항원 측정 방법 |
| JP7851928B2 (ja) | 2020-11-02 | 2026-04-27 | エフ． ホフマン－ラ ロシュ アーゲー | ＳＡＲＳ－ＣｏＶ－２ヌクレオカプシド抗体 |
| CN112816703A (zh) * | 2020-12-30 | 2021-05-18 | 北京联众泰克科技有限公司 | 用于抗缪勒管激素检测的组合物及应用和磁微球电化学发光免疫检测试剂盒与检测方法 |
| WO2022207628A1 (en) | 2021-03-30 | 2022-10-06 | F. Hoffmann-La Roche Ag | Scf as blood biomarker for the non-invasive diagnosis of endometriosis |
| WO2022207685A1 (en) | 2021-04-01 | 2022-10-06 | F. Hoffmann-La Roche Ag | Psp94 as blood biomarker for the non-invasive diagnosis of endometriosis |
| JP2024513474A (ja) | 2021-04-09 | 2024-03-25 | エフ． ホフマン－ラ ロシュ アーゲー | 異種ポリペプチドを発現する細胞クローンを選択するための方法 |
| CN117337394A (zh) | 2021-05-17 | 2024-01-02 | 豪夫迈·罗氏有限公司 | sFRP4作为血液生物标志物用于子宫腺肌病的非侵入性诊断 |
| WO2023021055A1 (en) | 2021-08-19 | 2023-02-23 | F. Hoffmann-La Roche Ag | Multivalent anti-variant fc-region antibodies and methods of use |
| WO2023072904A1 (en) | 2021-10-26 | 2023-05-04 | F. Hoffmann-La Roche Ag | Monoclonal antibodies specific for sars-cov-2 rbd |
| WO2023117325A1 (en) | 2021-12-21 | 2023-06-29 | F. Hoffmann-La Roche Ag | Method for the determination of hydrolytic activity |
| WO2023131594A1 (en) | 2022-01-05 | 2023-07-13 | F. Hoffmann-La Roche Ag | Derivatization of compounds in patient samples for therapeutic drug monitoring (tdm) |
| JP2025520600A (ja) | 2022-06-23 | 2025-07-03 | エフ． ホフマン－ラ ロシュ アーゲー | 子宮内膜症を診断するためおよび子宮内膜症の病期を分類するための方法 |
| EP4558826A1 (de) | 2022-07-22 | 2025-05-28 | F. Hoffmann-La Roche AG | Fibroblastenwachstumsfaktor-bindendes protein 1 (fgfbp1) als (blut) biomarker zur diagnose des polyzystischen ovarialsyndroms |
| JP2025524027A (ja) | 2022-07-22 | 2025-07-25 | エフ． ホフマン－ラ ロシュ アーゲー | 多嚢胞性卵巣症候群の診断のための（血液）バイオマーカーとしてのメテオリン様タンパク質（ｍｅｔｒｎｌ） |
| EP4558830A1 (de) | 2022-07-22 | 2025-05-28 | F. Hoffmann-La Roche AG | Leukotrien-a4-hydrolase (lta4h) als (blut) biomarker zur diagnose des polyzystischen ovarialsyndroms |
| AU2023329315A1 (en) | 2022-08-24 | 2025-01-16 | Amgen Inc. | Anti-drug antibody assays |
| CN121532654A (zh) | 2023-07-20 | 2026-02-13 | 豪夫迈·罗氏有限公司 | 针对抗体组合物的筛选方法 |
| CN121752901A (zh) | 2023-07-28 | 2026-03-27 | 豪夫迈·罗氏有限公司 | 作为子宫内膜异位症的生物标志物的血清EphA1 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4280815A (en) * | 1979-06-18 | 1981-07-28 | Technicon Instruments Corporation | Electrochemiluminescent immunoassay and apparatus therefor |
| US4652533A (en) * | 1983-04-28 | 1987-03-24 | Pandex Laboratories, Inc. | Method of solid phase immunoassay incorporating a luminescent label |
| US4687747A (en) * | 1984-07-02 | 1987-08-18 | Mallinckrodt, Inc. | Phenanthridinium ester as a labelling compound in luminometric immunoassay |
| DK365785A (da) * | 1984-09-17 | 1986-03-18 | Hoffmann La Roche | Metalcomplexer |
| JPH0737464B2 (ja) * | 1986-04-30 | 1995-04-26 | イゲン，インコーポレーテッド | エレクトロ化学ルミネセンスアツセイ |
| SE458968B (sv) * | 1987-06-16 | 1989-05-22 | Wallac Oy | Biospecifikt analysfoerfarande foer flera analyter i vilket ingaar partikelraekning och maerkning med fluorescerande maerksubstanser |
| CA2002083C (en) * | 1988-11-03 | 2001-01-09 | Haresh P. Shah | Enhanced electrochemiluminescence |
-
1989
- 1989-10-31 ZA ZA898290A patent/ZA898290B/xx unknown
- 1989-10-31 IL IL9216489A patent/IL92164A/en active IP Right Grant
- 1989-10-31 AU AU46357/89A patent/AU637775B2/en not_active Ceased
- 1989-10-31 SG SG1996011161A patent/SG60022A1/en unknown
- 1989-10-31 AT AT89913023T patent/ATE180057T1/de not_active IP Right Cessation
- 1989-10-31 WO PCT/US1989/004919 patent/WO1990005301A1/en not_active Ceased
- 1989-10-31 JP JP2500352A patent/JP2992974B2/ja not_active Expired - Lifetime
- 1989-10-31 EP EP96202510A patent/EP0757252A3/de not_active Ceased
- 1989-10-31 KR KR1019900701404A patent/KR0143993B1/ko not_active Expired - Fee Related
- 1989-10-31 DE DE68928994T patent/DE68928994T2/de not_active Expired - Lifetime
- 1989-10-31 EP EP89913023A patent/EP0446245B1/de not_active Expired - Lifetime
- 1989-11-02 CA CA002002101A patent/CA2002101C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU4635789A (en) | 1990-05-28 |
| JP2992974B2 (ja) | 1999-12-20 |
| DE68928994D1 (de) | 1999-06-17 |
| SG60022A1 (en) | 1999-02-22 |
| EP0757252A3 (de) | 1997-04-16 |
| EP0446245A1 (de) | 1991-09-18 |
| IL92164A0 (en) | 1990-07-12 |
| DE68928994T2 (de) | 1999-12-16 |
| JPH04502209A (ja) | 1992-04-16 |
| WO1990005301A1 (en) | 1990-05-17 |
| CA2002101A1 (en) | 1990-05-03 |
| EP0757252A2 (de) | 1997-02-05 |
| AU637775B2 (en) | 1993-06-10 |
| IL92164A (en) | 1996-01-19 |
| EP0446245B1 (de) | 1999-05-12 |
| EP0446245A4 (en) | 1991-11-13 |
| CA2002101C (en) | 2002-05-28 |
| KR0143993B1 (ko) | 1998-07-15 |
| ZA898290B (en) | 1991-06-26 |
| KR900702368A (ko) | 1990-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE180057T1 (de) | Elektrochemilumineszente testverfahren | |
| DE69229950D1 (de) | Verfahren für verbesserte lumineszenz-assays unter verwendung von teilchenkonzentration und chemilumineszenznachweis | |
| EP0647849A3 (de) | Nachweis der Anwesenheit von Analyten in einer Probe. | |
| EP1333274A3 (de) | Up-converting reporter Molekül für biologische und andere Testverfahren unter Verwendung von Laseranregungstechniken | |
| RU98116668A (ru) | Графитовые нанотрубки в люминесцентных анализах и способы проведения таких анализов | |
| NO900582D0 (no) | Maalemetode. | |
| ATE58600T1 (de) | Testverfahren. | |
| DE69029785D1 (de) | Kinetische Bestimmungsmethode für Endotoxin unter Verwendung von Limulus-Amoebocyten-Lysat und chromogenem Substrat | |
| DE3855535D1 (de) | Elektrochemilumineszente rhenium-fraktionen und verfahren | |
| DE69024955D1 (de) | Ermittlung und quantifizierung mehrerer analyten unter verwendung von markierungstechniken | |
| BR9300639A (pt) | Particulas marcadoras para uso no ensaio de uma amostra de um fluido biologico,processo pra ensaiar uma amostra de fluido biologico,e,processo para ensaiar uma amostra de sangue | |
| ES8203152A1 (es) | Un metodo para la determinacion de un analito biologico de interes utilizando tecnicas quimiluminiscentes. | |
| FI831688L (fi) | Test foer esterasaktivitet i ett flytande specimen | |
| SE8801011L (sv) | Foerfarande foer bestaemning av koncentrationen av en luminiscerande | |
| KR880700270A (ko) | 검체의 발광을 이용하여 검체가 존재가능한 매질에서 검체를 검출 및/또는 측정하기 위한 단상 방법 | |
| ATE217087T1 (de) | Chemilumineszierende derivate mit langer emissionswellenlänge und ihre verwendung in assays | |
| GB8811617D0 (en) | Assay | |
| ES2070715A1 (es) | Substratos de aminopeptidasas como sustancias de utilidad diagnosticas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner | ||
| EELA | Cancelled due to lapse of time |